Intravenous Dexamethasone Use and Outcomes in Children Hospitalized With Septic Arthritis
In this large cohort study, children with septic arthritis receiving dexamethasone had shorter hospital LOS and costs without higher 30-day revisit rates. Dexamethasone use varied widely across hospitals. These findings highlight the need for evaluation in a multicenter randomized trial.
Authors
- Mary C. Villani (ORCID: https://orcid.org/0000-0001-5370-4632)
- Pratichi Goenka
- Samir S. Shah (ORCID: https://orcid.org/0000-0001-7902-7000)
- Andrew S. Kern‐Goldberger (ORCID: https://orcid.org/0000-0003-0610-4292)
- Marcos Mestre
- Jessica L. Markham (ORCID: https://orcid.org/0000-0003-1616-7721)
- Marie E. Wang (ORCID: https://orcid.org/0000-0002-9216-2650)
- Laura H. Brower (ORCID: https://orcid.org/0000-0003-2947-9003)
- Matt Hall (ORCID: https://orcid.org/0000-0001-7778-5887)
- Alison Payson
- Jaime Rice Denning (ORCID: https://orcid.org/0000-0003-1743-4801)
Institutions
- Cincinnati Children's Hospital Medical Center (US)
- Northwell Health (US)
- Lucile Packard Children's Hospital (US)
- Hofstra University (US)
- Cleveland Clinic Lerner College of Medicine (US)
- Cohen Children's Medical Center (US)
- Miami Children's Hospital (US)
- Children's Hospital Association (US)
- Case Western Reserve University (US)
- University of Cincinnati (US)
- University of Missouri–Kansas City (US)
- The University of Texas Southwestern Medical Center (US)
- Stanford University (US)
Publication Details
- Journal
- Hospital Pediatrics
- Published
- 2025-04-06
- DOI
- https://doi.org/10.1542/hpeds.2024-008047
- Citations
- 1
- Primary Topic
- Sepsis Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- Agency for Healthcare Research and Quality